Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jade Maillou
Observed name:
J. Maillou
Institutions:
Centre Hospitalier de l’Université de Montréal,
Université de Montréal
Observed institutions:
Centre Hospitalier de l’Université de Montréal,
Université de Montréal
ORCID:
0009-0008-2475-9931
Observed ORCID:
0009-0008-2475-9931
OpenAlex ID:
A5094242556
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
2026
·
Sreya Duttagupta
, Meriem Messaoudene
, et al.
·
Nature Medicine
·
121
PDF
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
2024
·
Arielle Elkrief
, Eder Orlando Méndez-Salazar
, et al.
·
npj Precision Oncology
·
87
Abstract CT258: Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)
2024
·
Sreya Duttagupta
, Meriem Messaoudene
, et al.
·
Cancer Research
·
13
Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)
2025
·
Sreya Duttagupta
, Meriem Messaoudene
, et al.
·
Cancer Research
·
8
Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)
2025
·
Jade Maillou
, Reilly Pidgeon
, et al.
·
Cancer Research
·
3
73P Correlation between diet, microbiome composition and clinical outcomes in patients with non-small cell lung cancer
2024
·
J. Malo
, M. Benlaïfaoui
, et al.
·
ESMO Open
·
1
Abstract C065: Impact of polyethylene glycol bowel preparation on the gut microbiome composition and response to immune checkpoint inhibition
2026
·
Yongjia Hu
, Alyse Filin
, et al.
·
Cancer Immunology Research
CN104 Impact of fecal microbial transplantation on quality of life in patients with non-small cell lung cancer or melanoma undergoing immune checkpoint inhibitors
2025
·
J. Malo
, A-S. Renaud
, et al.
·
Annals of Oncology
LBA62 Phase I trial of camu camu prebiotic plus immunotherapy in patients with melanoma and non-small cell lung cancer (NSCLC)
2025
·
J. Maillou
, M. Messaoudene
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
9
Citation count:
233
H-index:
4
I10-index:
3
Year
Topic
Type